Fulgent Genetics, Inc. FLGT 深 滬
已收盤 04-02 16:00:00 美东时间
16.82
+0.380
+2.31%
華盛通- 最 高16.92
- 今 開16.34
- 成交量 55.62万股
- 最 低 16.1501
- 昨 收 16.44
- 總市值 5.25亿
- 52周最高 31.04
- 市盈率 靜 --
- 換手率 1.78%
- 52周最低 13.46
- 委 比 -62.32%
- 總股本 3123.06万
- 歷史最高 189.89
- 量 比 1.17
- 振 幅 4.68%
- 歷史最低 2.725
- 每 手 1
- 風險率 4.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Portnoy Law Firm probes Fulgent Genetics for possible securities fraud after 38% stock plunge
Portnoy Law Firm probes Fulgent Genetics for possible securities fraud after 38% stock plunge The Portnoy Law Firm said it has opened an investigation into possible securities fraud at Fulgent and may file a securities class action on behalf of investors. Fulgent shares fell USD 9.43, or 38%, to USD
03-13 21:02
Fulgent Genetics shares are trading lower after the company reported mixed Q4 financial results. The company also issued FY26 guidance below estimates.
Fulgent Genetics shares are trading lower after the company reported mixed Q4 f...
02-27 23:38
Fulgent Genetics Sees FY2026 Adj EPS $(1.45) vs $(0.32) Est; Sees Sales $350.000M vs $356.333M Est
Fulgent Genetics (NASDAQ:FLGT) is looking for FY2026 Adj EPS of $(1.45) vs $(0.32) analyst estimate. sees sales of $350.000 million vs $356.333 million analyst estimate.
02-27 20:04
Fulgent Genetics Q4 Earnings Assessment
The Q4 earnings report for Fulgent Genetics (NASDAQ:FLGT) was released on Frida...
02-27 20:02
Fulgent Genetics Q4 Adj. EPS $0.16 Beats $0.03 Estimate, Sales $83.336M Miss $85.381M Estimate
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.03 by 433.33 percent. This is a 300 percent increase over earnings of $0.04 per share from the
02-27 20:00
Earnings Scheduled For February 27, 2026
Companies Reporting Before The Bell • Escalade (NASDAQ:ESCA) is estimated to re...
02-27 19:11
Earnings Preview: Fulgent Genetics
Fulgent Genetics (NASDAQ:FLGT) is preparing to release its quarterly earnings o...
02-26 23:02
Fulgent Genetics Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results
Fulgent Genetics Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results Fulgent Genetics Inc. will announce its fourth quarter and full year 2025 financial results before the market opens on Friday, February 27, 2026. The results will be released on the Investor Relations section of th
02-12 20:31
Fulgent Genetics Chief Scientific Officer Hanlin Gao Reports Sale of Common Shares
Hanlin Gao, Chief Scientific Officer, reported a disposal of common shares of Fulgent Genetics Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by P...
2025-12-02 10:15
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
2025-11-12 11:43
